How many tablets of Febuxostat (Febuxostat) are recommended to be taken in a day to be safe and effective?
Febuxostat (Febuxostat) is a selective xanthine oxidase inhibitor mainly used to treat patients with hyperuricemia and gout. Its mechanism of action is to reduce uric acid production by inhibiting xanthine oxidase, thereby reducing serum uric acid levels and preventing gout attacks and uric acid crystal deposition. A reasonable daily dose is the key to ensuring efficacy and reducing adverse reactions.
Clinically, the commonly used dose of febuxostat is once daily, and the initial recommended dose is40 mg. If the patient's serum uric acid level does not reach the target (usually less than 360 μmol/L), it can be increased to 80mg/ days under the guidance of a doctor. Doses above 80mg are generally not recommended for long-term use because high doses may increase cardiovascular risk. Under normal circumstances, one tablet a day can maintain the stability of serum uric acid and facilitate long-term compliance for patients.

In terms of medication safety, serum uric acid, liver function and renal function need to be monitored regularly while taking febuxostat. Some patients may experience mild liver function abnormalities, rash or gastrointestinal discomfort. If there is obvious discomfort, they should seek medical treatment in time and adjust the dose. For patients with a history of severe cardiovascular disease, they need to be used with caution under the guidance of a doctor to reduce potential risks.
In short, taking febuxostat daily40mg-80mg is a safe and effective routine regimen. Individualized adjustments should be based on serum uric acid levels, liver and kidney function, and cardiovascular risk. Regular review and healthy lifestyle, such as diet control and moderate exercise, should be maintained throughout the treatment process to further enhance the efficacy of the medication and reduce the risk of gout attacks.
Reference link:https://www.drugs.com
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)